Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-05

Clinical Trial Update: A Study to Explore the Role of Gut Flora in ALS

View source ↗

Summary

This clinical trial evaluating the role of gut flora in amyotrophic lateral sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ProgenaBiome | Conditions: ALS, Amyotrophic Lateral Sclerosis | Status: WITHDRAWN